Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Dana-Farber Cancer Institute
CERo Therapeutics Holdings, Inc.
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Ossium Health, Inc.
City of Hope Medical Center
Institute of Hematology & Blood Diseases Hospital, China
St. Jude Children's Research Hospital
AvenCell Therapeutics, Inc.
Case Comprehensive Cancer Center
University of Arizona
Dana-Farber Cancer Institute
University of Pennsylvania
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Massachusetts General Hospital
Gilead Sciences
University of Pennsylvania
University of Pennsylvania
City of Hope Medical Center
Caribou Biosciences, Inc.
City of Hope Medical Center
City of Hope Medical Center
AvenCell Therapeutics, Inc.
Nkarta, Inc.
Institute of Hematology & Blood Diseases Hospital, China
Masonic Cancer Center, University of Minnesota
University of Colorado, Denver
Fate Therapeutics
Ohio State University Comprehensive Cancer Center
Fate Therapeutics
Melbourne Health
Shanghai Pudong Hospital
M.D. Anderson Cancer Center
Zhejiang University
Zhejiang University
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Xinqiao Hospital of Chongqing
TC Biopharm
Washington University School of Medicine
Peking University People's Hospital
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Celularity Incorporated
Celyad Oncology SA
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center